HCM NASDAQ
HUTCHMED (China) Limited
1W: +1.9%
1M: +17.9%
3M: +21.9%
YTD: +4.0%
1Y: -11.0%
3Y: -14.9%
5Y: -61.2%
$14.20
-0.37 (-2.54%)
Weekly Expected Move ±6.5%
$12
$13
$14
$15
$16
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Revenue Segmentation
By Product / Service
By Geography
Revenue by Segment (5-Year Trend)
Income Trends
Revenue
$550M
-12.7% ▼
5Y CAGR: +19.3%
Gross Profit
$213M
-24.4% ▼
5Y CAGR: +40.1%
Operating Income
-$55M
-34.8% ▼
Net Income
$458M
+1114.2% ▲
EPS (Diluted)
$2.60
+1103.7% ▲
EBITDA
-$41M
-393.4% ▼
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $356M | $426M | $838M | $630M | $550M |
| YoY Growth | +56.2% | +19.7% | +96.5% | -24.8% | -12.7% |
| Cost of Revenue | $258M | $311M | $384M | $349M | $337M |
| Gross Profit | $98M | $115M | $454M | $281M | $213M |
| Gross Margin | 27.5% | 27.0% | 54.1% | 44.6% | 38.7% |
| R&D Expenses | $207M | $268M | $303M | $213M | $164M |
| SG&A Expenses | $127M | $136M | $133M | $113M | $103M |
| Operating Expenses | $426M | $523M | $436M | $322M | $267M |
| Operating Income | -$344M | -$410M | $18M | -$44M | -$55M |
| Operating Margin | -96.7% | -96.1% | 2.2% | -6.9% | -10.0% |
| Interest Expense | $592K | $652K | $759K | $3M | $3M |
| Income Before Tax | -$155M | -$360M | $106M | $45M | $523M |
| Tax Expense | $12M | -$283K | $5M | $7M | $64M |
| Net Income | -$195M | -$361M | $101M | $38M | $458M |
| Net Margin | -54.7% | -84.6% | 12.0% | 6.0% | 83.3% |
| EPS (Diluted) | $-1.25 | $-2.15 | $0.60 | $0.22 | $2.60 |
| EBITDA | -$208M | -$401M | $67M | $14M | -$41M |
| Shares Outstanding | 159M | 169M | 174M | 175M | 175M |